Robert Mróz - Concepedia

Author

Robert Mróz

Medical University of Białystok ORCID

Also Known As

Ewa Jassem, Janusz Milanowski, Mroz RM, Mroz, Robert, Paweł Lisowski, R M Mroz, R M Mróz, R Mroz, R Mróz, R. M. Mroz

139

Publications

4.9K

Citations

H-Index

103

Concepts

All Affiliations

Medical University of Białystok Medical University of Silesia Medical University of Lodz Medical University of Warsaw University of Saskatchewan

About

Robert Mróz is an author at Medical University of Białystok specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	24	3.6K
2	Allergy	7	7	419
3	Public Health	3	3	200
4	Engineering	2	2	44
5	Health Sciences	1	1	10

Robert Mróz

Publications

Citations

H-Index

Page 1

	Year	Citations
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen, The Lancet Platinum–etoposide Versus Platinum–etoposideMedicinePharmacologyImmune Checkpoint InhibitorFirst-line Treatment	2019	2.1K
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen, The Lancet Oncology Platinum–etoposide Versus Platinum–etoposideMedicinePathologyImmune Checkpoint InhibitorFirst-line Treatment	2020	662
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, The Lancet Respiratory Medicine AsthmaRheumatologyExtension TrialAllergyAllergy Medicine	2018	298
Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways Robert Mróz, Roel P. F. Schins, H. Li, European Respiratory Journal Dna DamageRadiation EffectMolecular BiologyNanotoxicologyRadiation Biology	2007	144
Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study Jutta Beier, Anne‐Marie Kirsten, Robert Mróz, COPD Journal of Chronic Obstructive Pulmonary Disease	2013	106
The Prevalence of Cigarette and E-cigarette Smoking Among Students in Central and Eastern Europe—Results of the YUPESS Study Grzegorz Brożek, Mateusz Jankowski, Joshua Lawson, International Journal of Environmental Research and Public Health	2019	93
Nanoparticle carbon black driven DNA damage induces growth arrest and AP-1 and NFkappaB DNA binding in lung epithelial A549 cell line. Robert Mróz, Roel P. F. Schins, H Li, PubMed Lung Epithelial CellsTumor MicroenvironmentLung InflammationOncogenic AgentNfkappab Dna Binding	2007	61
Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study. Robert Mróz, Paweł Lisowski, Agnieszka Tycińska, PubMed	2015	56
Asthma-COPD Overlap—A Discordance Between Patient Populations Defined by Different Diagnostic Criteria Adam Barczyk, Marta Maskey‐Warzęchowska, Katarzyna Górska, The Journal of Allergy and Clinical Immunology In Practice AsthmaEpidemiologyOccupational Lung DiseasesAdvanced Lung DiseaseRespiratory Diseases	2019	46
Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. Robert Mróz, J Noparlik, E Chyczewska, PubMed AsthmaInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationImmunology	2007	41

Page 1